Temazepam Capsule
FDA Label NDC 71610-626

36 label sections · Submitted to the FDA by Aphena Pharma Solutions - Tennessee, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Aphena Pharma Solutions - Tennessee, Llc for the product Temazepam (NDC 71610-626). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, 7.5 mg, 15 mg, 22.5 mg, and 30 mg capsules, pharmacokinetics, bioavailability, induction, and plasma levels, elimination rate of benzodiazepine hypnotics and profile of common untoward effects, controlled trials supporting efficacy, indications and usage, risks from concomitant use with opioids, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.